SlidesetHIVAsia-Pacific HIV Clinical Forum 2017Antiretroviral Treatment Strategies: Clinical Case Presentation- Dr. Chia-Jui YangView Slideset
CBCharles BoucherMD, PhDSlidesetHIVAsia-Pacific HIV Clinical Forum 2017HIV Macroprevention, epidemiology, phylogenics and networks- Charles Boucher, MD, PhDView Slideset
IGIshwar GiladaMD, DDV, FCPSSlidesetHIVAsia-Pacific HIV Clinical Forum 2017Clinical case presentation- Ishwar Gilada, MD, DDV, FCPSView Slideset
FZFujie ZhangMD, PhDSlidesetHIVAsia-Pacific HIV Clinical Forum 2017ARV Side effects and Management- Fujie Zhang, MD, PhDView Slideset
SlidesetHIVAsia-Pacific HIV Clinical Forum 2017Clinical case presentation- Dr. Wilson LamView Slideset
DKDaniel KuritzkesMDSlidesetHIVAsia-Pacific HIV Clinical Forum 2017Understanding Viral Suppression- Daniel Kuritzkes, MDView Slideset
APAnton PozniakMD, FRCPSlidesetHIVGlobal HIV Clinical Forum 2017Optimizing Clinical Utility of Integrase Inhibitors- Anton Pozniak, MD, FRCPView Slideset
PCPedro CahnMD, PhDSlidesetHIVGlobal HIV Clinical Forum 2017Clinical Case -Reduced Drug Regimen- Pedro Cahn, MD, PhDView Slideset
PCPep CollMD, MSSlidesetHIVGlobal HIV Clinical Forum 2017The Role of Integrase Inhibitors during HIV prevention- Pep Coll, MDView Slideset
SlidesetHIVGlobal HIV Clinical Forum 2017Clinical case of transmitted resistance to HIV Integrase Inhibitors- Dr. Carmen María González DomenechView Slideset
SlidesetHIVGlobal HIV Clinical Forum 2017Mutations to Integrase inhibitors in real life- Dr. Isabel Viciana RamosView Slideset
SWSharon WalmsleyCM, MD, FRCPCSlidesetHIVGlobal HIV Clinical Forum 2017Optimal Use of Integrase Inhibitors in Women- Sharon Walmsley, FRCPC, MD, MSCView Slideset
